4//SEC Filing
Paull Robert Bradley 4
Accession 0001415889-21-003122
CIK 0001479419other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:30 PM ET
Size
6.0 KB
Accession
0001415889-21-003122
Insider Transaction Report
Form 4
Paull Robert Bradley
Director10% Owner
Transactions
- Award
Common Stock
2021-06-17+20,000→ 40,000 total
Holdings
- 2,361(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service with the Issuer, the RSUs will vest as to 100% of the shares underlying the RSUs on the earlier of (i) June 17, 2022 or (ii) the date of the first annual meeting following June 17, 2021.
- [F2]Includes 20,000 unvested RSUs.
- [F3]These shares are owned directly by the Paull Revocable Trust U/A/D 04/06/2012 (the "Trust"), and indirectly by Mr. Paull as co-trustee of the Trust.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001711254
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:30 PM ET
- Size
- 6.0 KB